| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 2.471.125 $ | 73,33 | 135.223 | |||||||
| ORGANON & COMPANY | Organon & Company | EC | 68622V106 | Long | Börsenkurs (Stufe 1) | 91.915 $ | 2,73 | 6.937 | |
| CORCEPT THERAPEUTICS INC | Corcept Therapeutics, Inc. | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 61.220 $ | 1,82 | 1.316 | |
| ENLIVEN THERAPEUTICS INC | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 59.619 $ | 1,77 | 1.446 | |
| AXSOME THERAPEUTICS INC | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 57.755 $ | 1,71 | 278 | |
| OMEROS CORP | Omeros Corporation | EC | 682143102 | Long | Börsenkurs (Stufe 1) | 54.341 $ | 1,61 | 3.722 | |
| PERRIGO COMPANY PLC | Perrigo Company plc | EC | G97822103 | Long | Börsenkurs (Stufe 1) | 53.588 $ | 1,59 | 4.526 | |
| DEFINIUM THERAPEUTICS INC | Definium Therapeutics, Inc. | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 52.140 $ | 1,55 | 2.383 | |
| NEKTAR THERAPEUTICS | Nektar Therapeutics | EC | 640268306 | Long | Börsenkurs (Stufe 1) | 51.449 $ | 1,53 | 605 | |
| TREVI THERAPEUTICS INC | Trevi Therapeutics, Inc. | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 51.160 $ | 1,52 | 3.718 | |
| TERNS PHARMACEUTICALS INC | Terns Pharmaceuticals, Inc. | EC | 880881107 | Long | Börsenkurs (Stufe 1) | 50.231 $ | 1,49 | 949 | |
| INDIVIOR PHARMACEUTICALS INC | Indivior Pharmaceuticals, Inc. | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 49.727 $ | 1,48 | 1.352 | |
| PACIRA BIOSCIENCES INC | Pacira BioSciences, Inc. | EC | 695127100 | Long | Börsenkurs (Stufe 1) | 49.578 $ | 1,47 | 1.945 | |
| HARROW INC | Harrow, Inc. | EC | 415858109 | Long | Börsenkurs (Stufe 1) | 48.717 $ | 1,45 | 1.202 | |
| JAZZ PHARMACEUTICALS PLC | Jazz Pharmaceuticals plc | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 48.522 $ | 1,44 | 239 | |
| HARMONY BIOSCIENCES HOLDINGS INC | Harmony Biosciences Holdings, Inc. | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 48.203 $ | 1,43 | 1.542 | |
| ROYALTY PHARMA PLC | Royalty Pharma plc | EC | G7709Q104 | Long | Börsenkurs (Stufe 1) | 47.636 $ | 1,41 | 951 | |
| AMYLYX PHARMACEUTICALS INC | Amylyx Pharmaceuticals, Inc. | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 47.584 $ | 1,41 | 2.974 | |
| VIATRIS INC | Viatris, Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 47.479 $ | 1,41 | 3.178 | |
| CRINETICS PHARMACEUTICALS INC | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 46.575 $ | 1,38 | 1.201 | |
| ANI PHARMACEUTICALS INC | ANI Pharmaceuticals, Inc. | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 46.240 $ | 1,37 | 582 | |
| LIGAND PHARMACEUTICALS INC | Ligand Pharmaceuticals, Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 46.119 $ | 1,37 | 201 | |
| MBX BIOSCIENCES INC | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 45.632 $ | 1,35 | 1.510 | |
| INNOVIVA INC | Innoviva, Inc. | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 45.520 $ | 1,35 | 1.980 | |
| LIQUIDIA CORP | Liquidia Corporation | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 45.131 $ | 1,34 | 1.151 | |
| AMNEAL PHARMACEUTICALS INC | Amneal Pharmaceuticals, Inc. | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 44.955 $ | 1,33 | 3.493 | |
| XERIS BIOPHARMA HOLDINGS INC | Xeris Biopharma Holdings, Inc. | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 44.939 $ | 1,33 | 7.337 | |
| BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb Company | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 44.837 $ | 1,33 | 740 | |
| EDGEWISE THERAPEUTICS INC | Edgewise Therapeutics, Inc. | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 44.366 $ | 1,32 | 1.433 | |
| OCULAR THERAPEUTIX INC | Ocular Therapeutix, Inc. | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 43.786 $ | 1,30 | 4.673 | |
| PFIZER INC | Pfizer, Inc. | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 43.414 $ | 1,29 | 1.626 | |
| NUVATION BIO INC | Nuvation Bio, Inc. | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 43.045 $ | 1,28 | 9.673 | |
| ZOETIS INC | Zoetis, Inc. | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 42.654 $ | 1,27 | 371 | |
| ELANCO ANIMAL HEALTH INC | Elanco Animal Health, Inc. | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 42.346 $ | 1,26 | 1.893 | |
| JOHNSON & JOHNSON | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 42.063 $ | 1,25 | 183 | |
| COLLEGIUM PHARMACEUTICAL INC | Collegium Pharmaceutical, Inc. | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 42.028 $ | 1,25 | 1.246 | |
| MERCK & COMPANY INC | Merck & Company, Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 41.707 $ | 1,24 | 382 | |
| ALUMIS INC | Alumis, Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 41.627 $ | 1,24 | 1.686 | |
| ELI LILLY & COMPANY | Eli Lilly & Company | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 41.122 $ | 1,22 | 44 | |
| TARSUS PHARMACEUTICALS INC | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 40.392 $ | 1,20 | 635 | |
| SUPERNUS PHARMACEUTICALS INC | Supernus Pharmaceuticals, Inc. | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 40.032 $ | 1,19 | 834 | |
| PHIBRO ANIMAL HEALTH CORP | Phibro Animal Health Corporation | EC | 71742Q106 | Long | Börsenkurs (Stufe 1) | 39.832 $ | 1,18 | 749 | |
| EYEPOINT INC | EyePoint Pharmaceuticals, Inc. | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 39.283 $ | 1,17 | 2.976 | |
| PRESTIGE CONSUMER HEALTHCARE INC | Prestige Consumer Healthcare, Inc. | EC | 74112D101 | Long | Börsenkurs (Stufe 1) | 38.579 $ | 1,14 | 685 | |
| AMPHASTAR PHARMACEUTICALS INC | Amphastar Pharmaceuticals, Inc. | EC | 03209R103 | Long | Börsenkurs (Stufe 1) | 37.596 $ | 1,12 | 1.712 | |
| THERAVANCE BIOPHARMA INC | Theravance Biopharma, Inc. | EC | G8807B106 | Long | Börsenkurs (Stufe 1) | 33.848 $ | 1,00 | 2.022 | |
| PHATHOM PHARMACEUTICALS INC | Phathom Pharmaceuticals, Inc. | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 33.600 $ | 1,00 | 3.000 | |
| RAPPORT THERAPEUTICS INC | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 33.528 $ | 0,99 | 1.012 | |
| ESPERION THERAPEUTICS INC | Esperion Therapeutics, Inc. | EC | 29664W105 | Long | Börsenkurs (Stufe 1) | 33.012 $ | 0,98 | 16.506 | |
| CORMEDIX INC | CorMedix, Inc. | EC | 21900C308 | Long | Börsenkurs (Stufe 1) | 31.643 $ | 0,94 | 4.169 | |
| ARVINAS INC | Arvinas, Inc. | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 26.958 $ | 0,80 | 2.723 | |
| BIOAGE LABS INC | BioAge Labs, Inc. | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 26.741 $ | 0,79 | 1.587 | |
| ZEVRA THERAPEUTICS INC | Zevra Therapeutics, Inc. | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 24.845 $ | 0,74 | 2.443 | |
| MAZE THERAPEUTICS INC | Maze Therapeutics, Inc. | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 23.390 $ | 0,69 | 880 | |
| SEPTERNA INC | Septerna, Inc. | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 22.976 $ | 0,68 | 967 | |
| WAVE LIFE SCIENCES LTD | WaVe Life Sciences Ltd. | EC | Y95308105 | Long | Börsenkurs (Stufe 1) | 22.260 $ | 0,66 | 3.153 | |
| LB PHARMACEUTICALS INC | LB Pharmaceuticals, Inc. | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 21.277 $ | 0,63 | 671 | |
| FULCRUM THERAPEUTICS INC | Fulcrum Therapeutics, Inc. | EC | 359616109 | Long | Börsenkurs (Stufe 1) | 19.714 $ | 0,59 | 2.765 | |
| AQUESTIVE THERAPEUTICS INC | Aquestive Therapeutics, Inc. | EC | 03843E104 | Long | Börsenkurs (Stufe 1) | 18.512 $ | 0,55 | 4.515 | |
| ALTO NEUROSCIENCE INC | Alto Neuroscience Inc | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 14.139 $ | 0,42 | 551 | |
| 2.471.125 $ | 73,33 | 135.223 |